Skip to main content

Table 2 Consistency of subgroup labelling between t-tau and p-tau (ADC and ADNI), and across platforms (ADNI)

From: Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts

Biomarker: Platform

 

ADC p-tau Innotest

ADC T-tau: Innotest

Subgroup

1

2

3

4

1

960

83

0

0

2

140

661

58

0

3

6

209

399

18

4

0

0

33

60

 

P-tau: Luminex

T-tau: Luminex

Subgroup

1

2

3

4

1

210

108

13

1

2

116

261

89

2

3

3

159

138

8

4

0

10

76

19

 

P-tau: Elecsys

   

T-tau: Elecsys

Subgroup

1

2

3

4

1

290

0

0

0

2

186

309

0

0

3

0

145

185

2

4

0

0

14

61

 

T-tau: Elecsys

   

T-tau: Luminex

Subgroup

1

2

3

4

1

256

70

1

0

2

35

381

43

1

3

0

44

255

4

4

0

0

33

70

 

P-tau: Elecsys

   

P-tau: Luminex

Subgroup

1

2

3

4

1

287

36

0

0

2

167

296

63

2

3

21

119

121

48

4

0

1

13

12